Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
5,370 results
  • Safety and efficacy of daily Revactin® in men with erectile dysfunction: a 3-month pilot study. [Journal Article]
  • TATransl Androl Urol 2018; 7(2):266-273
  • Nguyen S, Rajfer J, Shaheen M
  • CONCLUSIONS: Revactin®, a combination of 3 nutraceuticals packaged with L-citrulline, appears to have the same excellent safety profile known for each of its individual four components. The early improvement in EF seen in about 50% of these patients may be due to the elevated levels of cGMP produced via this iNOS-cGMP pathway. Further longitudinal studies with Revactin® appear warranted.
New Search Next